Project Details
| Status | Active |
|---|---|
| Effective start/end date | 16/10/24 → 15/10/29 |
A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study with Single Blind Sentinel period to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IGNX001 in Peanut-Allergic Adults and Older Adolescents
- Barnes, Sara (Primary Chief Investigator (PCI))
Project: Research